Zhang et al., 2008 - Google Patents
Clinical significance of increased CD4+ CD25− Foxp3+ T cells in patients with new-onset systemic lupus erythematosusZhang et al., 2008
View PDF- Document ID
- 7936953711208412323
- Author
- Zhang B
- Zhang X
- Tang F
- Zhu L
- Liu Y
- Lipsky P
- Publication year
- Publication venue
- Annals of the rheumatic diseases
External Links
Snippet
Objective: To investigate the expressions of Foxp3 and CD25 on CD4+ T cells from patients with new-onset systemic lupus erythematosus (SLE) and assess their clinical significance. Methods: 10 patients with active (systemic lupus erythematosus Disease Activity Index …
- 101700064140 FOXP3 0 title abstract description 69
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | Clinical significance of increased CD4+ CD25− Foxp3+ T cells in patients with new-onset systemic lupus erythematosus | |
| Alexander et al. | Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus | |
| Rao et al. | Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis | |
| Zhang et al. | A distinct subset of plasmacytoid dendritic cells induces activation and differentiation of B and T lymphocytes | |
| Barbosa et al. | Monocyte and lymphocyte activation in bipolar disorder: a new piece in the puzzle of immune dysfunction in mood disorders | |
| Patas et al. | T cell phenotype and T cell receptor repertoire in patients with major depressive disorder | |
| Nguyen et al. | Loss of Siglec expression on T lymphocytes during human evolution | |
| Cao et al. | Autoreactive T cells from patients with myasthenia gravis are characterized by elevated IL-17, IFN-γ, and GM-CSF and diminished IL-10 production | |
| Pesenacker et al. | CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines | |
| Quandt et al. | Peripheral CD4CD8 double positive T cells with a distinct helper cytokine profile are increased in rheumatoid arthritis | |
| Wang et al. | Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood | |
| Santarlasci et al. | Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion | |
| Longhi et al. | Characterization of human CD39+ Th17 cells with suppressor activity and modulation in inflammatory bowel disease | |
| Booth et al. | Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO | |
| Flores-Borja et al. | Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis | |
| Bonelli et al. | Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis | |
| Kurkó et al. | Identification of myeloid-derived suppressor cells in the synovial fluid of patients with rheumatoid arthritis: a pilot study | |
| Soler et al. | Psoriasis patients exhibit impairment of the high potency CCR5+ T regulatory cell subset | |
| Yang et al. | Natural variation in interleukin-2 sensitivity influences regulatory T-cell frequency and function in individuals with long-standing type 1 diabetes | |
| Szegedi et al. | Regulatory T cells in atopic dermatitis: epidermal dendritic cell clusters may contribute to their local expansion | |
| Cao et al. | FOXP3 identifies regulatory CD25brightCD4+ T cells in rheumatic joints | |
| Zóka et al. | Extension of the CD4+ Foxp3+ CD25−/low regulatory T-cell subpopulation in type 1 diabetes mellitus | |
| Sugiyama et al. | CD4+ CD25high regulatory T cells are markedly decreased in blood of patients with pemphigus vulgaris | |
| Oras et al. | A study of 51 subtypes of peripheral blood immune cells in newly diagnosed young type 1 diabetes patients | |
| Brusko et al. | Assessing the in vitro suppressive capacity of regulatory T cells |